Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.

Autor: Guillén-Del-Castillo A; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Meseguer ML; Pneumology Department, Hospital Universitario Vall d'Hebrón, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain. manuelop@vhebron.net., Fonollosa-Pla V; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Giménez BS; Pneumology Department, Hospital Universitario Vall d'Hebrón, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Physiology Department, Universitat Autònoma de Barcelona, Barcelona, Spain., Colunga-Argüelles D; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain., Revilla-López E; Pneumology Department, Hospital Universitario Vall d'Hebrón, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain., Rubio-Rivas M; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Ropero MJC; Pulmonary Hypertension Unit, Cardiology Department of Hospital, Universitario, 12 de Octubre, Madrid, Spain., Argibay A; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain., Barberá JA; Pulmonary Medicine Department, Hospital Clínic de Barcelona/Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain., Salas XP; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona, Spain., Meñaca AM; Pneumology Department, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain., Vuelta ABM; Department of Internal Medicine, Hospital General San Jorge, Huesca, Spain., Padrón AL; Cardiology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Comet LS; Department of Internal Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain., Morera JAD; Pneumology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain., González-Echávarri C; Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain., Mombiela T; Cardiology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Ortego-Centeno N; Inst Invest Biosanitaria Ibs Granada, Department of Internal Medicine, Unit of Systemic Autoimmune Diseases, Hospital Universitario San Cecilio, Granada, Spain.; Department of Medicine, Facultad de Medicina, Hospital Universitario San Cecilio, Granada, Spain., González MM; Pneumology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain., Tolosa-Vilella C; Department of Internal Medicine, Parc Taulí, Hospital Universitario, Sabadell, Barcelona, Spain., Blanco I; Pulmonary Medicine Department, Hospital Clínic de Barcelona/Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain., Subías PE; Pulmonary Hypertension Unit, Cardiology Department of Hospital, Universitario, 12 de Octubre, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV)/Instituto de Salud Carlos III, Madrid, Spain., Simeón-Aznar CP; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain.

Publikováno v: Scientific reports [Sci Rep] 2022 Jul 28; Vol. 12 (1), pp. 12947. Date of Electronic Publication: 2022 Jul 28.